Thomas Liesegang, MD, received his medical degree from New York University and completed
a medical internship at Duke University, followed by a residency at the Bascom Palmer Eye Institute. He then went on to complete a fellowship
in external ocular disease and corneal surgery at Baylor College of Medicine in Houston, Texas.
Dr Liesegang has taught and published
extensively in the areas of corneal and external eye disease, with over 200 publications. In addition to serving as the Editor-in-Chief
of the American Journal of Ophthalmology, he also serves as the Editor of the Transactions of the American Ophthalmological
Society. He was previously the Abstract Editor of the AJO. Heserves on the International Council of Ophthalmology's Task Force
on Ophthalmology Continuing Education and on the Board of Directors of the Pan American Association of Ophthalmologists.
Dr Liesegang
has served as the American Academy of Ophthalmology's Senior Secretary for Clinical Education since 2001. Among other Academy positions
Dr Liesegang has held are: Secretary for Instruction from 1995 to 2000; Associate Secretary of the Ophthalmic Knowledge Assessment Program
committee from 1991 to 1995; a member of the PreferredPractice Pattern committee; and a number of Task Forces and Liaison committees.
He currently serves as Chair of the AAO's Ophthalmic Clinical Education Committee, Chair of the CME committee, and as a member of the
EyeNet Advisory Board and the Committee on Aging. Dr Liesegang has practiced at the Mayo Clinic for 28 years, first in Rochester, Minnesota
and later in Jacksonville, Florida where he is the Louis and Evelyn Krueger Professor in the Department of Ophthalmology.
H. E. Grossniklaus, Atlanta, GA
Hans E. Grossniklaus, MD, MBA is the Calhoun Jr. Professor of Ophthalmology and Pathology,
Director of the L.F. Montgomery Laboratory, and Vice Chairman of the Department of Ophthalmology, Emory University School of Medicine,
Atlanta, Georgia. He received a BA in chemistry and zoology from Miami University in 1976, MD from Ohio State University in 1980, and
MBA from Emory University in 2006. He completed residencies in ophthalmology and pathology at Case Western Reserve University, in 1985
and 1988 and fellowships in ophthalmic pathology at the Wilmer Institute, Johns Hopkins University in 1985 and the Armed Forces Institute
of Pathology in 1989. He has had over 20 visiting professorships. His areas of research interest are control of eye melanoma metastasis
and pathobiology of choroidal neovascularization.
Dr. Grossniklaus is a recipient of the American Academy of Ophthalmology Senior
Honor Award and Secretariat Award. He has also received the Heed Award, the W. R. Green Lecture Award, and the Research to Prevent Blindness
Physician Scientist Award.
He currently serves on the editorial boards of five journals and is the past chair of the American Academy
of Ophthalmology Basic and Clinical Science Course Section 4, Ophthalmic Pathology and Intraocular Tumors. He has over 300 publications
in peer reviewed journals.
G. N. Holland, Los Angeles, CA
Gary N. Holland, M.D. is Chief of the Cornea-External Ocular Disease & Uveitis Division of
the Department of Ophthalmology, David Geffen School of Medicine at UCLA, and is a member of the Jules Stein Eye Institute. He is first
recipient of the David May II Professorship of Ophthalmology (2002), which honors one of the founding members of the Institute's Board
of Trustees and a prominent member of the Los Angeles community. He is also Director of the Ocular Inflammatory Disease Center, Jules
Stein Eye Institute, and Director of the Institute's Clinical Research Center, which was created to provide support services for individuals
engaged in patient-based research.
Dr. Holland grew up in southern California where he undertook much of his training. He obtained
a Bachelor of Science degree in biological sciences at the University of California, Irvine (1975) and his medical degree at the UCLA
School of Medicine, where he also completed his residency training in ophthalmology. He undertook fellowship training in both uveitis/external
ocular diseases (Francis I. Proctor Foundation, University of California, San Francisco, 1983-1984) and corneal diseases and surgery
(Emory University, 1984-1985). He returned to the UCLA Department of Ophthalmology as a faculty member in 1985.
Dr. Holland is
especially interested in infectious diseases of the eye. In 1981, he was the first to describe the ophthalmic manifestations of AIDS.
He has continued to be involved in the study of CMV retinitis and other AIDS-related ophthalmic problems. Dr. Holland also has a long-standing
interest in ocular toxoplasmosis, having first investigated the disease in a non-human primate model during fellowship training at the
Francis I. Proctor Foundation. He is currently working with investigators in Brazil and Europe to understand the clinical features of
ocular toxoplasmosis more thoroughly and to identify factors related to severity of disease.
Since 1993, Dr. Holland has served
as Associate Editor (now Senior Associate Editor) of the American Journal of Ophthalmology. He is President-Elect of the American
Uveitis Society, and is a member of the International Council of the International Ocular Inflammation Society. He is a member of the
ARVO Ethics and Regulations in Human Research Committee, and has recently assumed the responsibility of team leader for the American
Academy of Ophthalmology's new Subspecialty Clinical Updates on uveitis. He is Co-Editor of the textbook Ocular Infection & Immunity.
P. K. Kaiser, Cleveland, OH
Peter K. Kaiser, M.D. is Director of the Clinical Research Center of the Cole Eye Institute at
the Cleveland Clinic Foundation. Dr. Kaiser received his medical degree magna cum laude from Harvard Medical School in Boston, Massachusetts,
and completed an internship in internal medicine at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye
and Ear Infirmary in Boston, and a vitreoretinal fellowship at Bascom Palmer Eye Institute in Miami, Florida.
Actively involved
in retinal clinical research, Dr. Kaiser currently is Study Chairman of the Visudyne In Occult (VIO) Trial, Study Vice Chairman of the
CUTS Trial, and principal investigator in multiple national, multicenter clinical trials. Complementing his research endeavors, Dr.
Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international
conferences. He is a major contributor to the medical literature having authored several ophthalmology texts, and more than 100 book
chapters, original reports, electronic publications, and abstracts. He is an Associate Editor of the American Journal of Ophthalmology.
Dr. Kaiser has been recognized by the American Academy of Ophthalmology and Vitreous Society with Honor and Senior Honor Awards, and
is listed on the Best Doctors in America List. He is the team ophthalmologist for the Cleveland Browns (National Football league), Cleveland
Cavaliers (National Basketball Association), and the Cleveland Barons (International Hockey League).
P. R. Lichter, Ann Arbor, MI
Paul R. Lichter, M.D. F. Bruce Fralick Professor of Ophthalmology and
Visual Sciences Chair, Department of Ophthalmology and Visual Sciences Director, W.K. Kellogg Eye Center
University of Michigan
Dr. Lichter is the F. Bruce Fralick Professor of Ophthalmology and Visual Sciences
and Chair of the University of Michigan's Department of Ophthalmology and Visual Sciences, a department founded in 1872. In addition,
Lichter serves as Director of the University's W.K. Kellogg Eye Center. He is a native of Detroit and received his undergraduate, medical
school, and ophthalmology residency education at the University of Michigan.
Dr. Lichter obtained his glaucoma fellowship training
at the University of California, San Francisco, under Robert N. Shaffer, M.D. Lichter's research and clinical interests involve glaucoma,
clinical trials, and genetics. He has chaired the Collaborative Initial Glaucoma Treatment Study (CIGTS), a 14-center study sponsored
by the National Eye Institute (NEI), which compares the effect of initial medication versus initial filtering surgery on visual function
and quality of life in patients who had been newly-diagnosed with open-angle glaucoma. In addition, Dr. Lichter currently serves as
a co-investigator on two NEI-sponsored grants involving the genetics of glaucoma. He has over 200 publications to his credit including
scientific articles, editorials, and book chapters and has delivered over 30 named lectures, including the Edward Jackson Memorial Lecture
in 1993.
Currently Dr. Lichter is Secretary-General of Academia Ophthalmologica Internationalis, a Director of The Heed Ophthalmic
Foundation, and Chairman of the Society of Heed Fellows. Dr. Lichter is past Editor-in-Chief of the journal Ophthalmology and currently serves as an Associate Editor of the American Journal of Ophthalmology. In 1996, Lichter served as the 100th
President of the American Academy of Ophthalmology. He is also a Past President of the Association of University Professors of Ophthalmology,
the American Ophthalmological Society, the Pan American Association of Ophthalmology, the Pan American Glaucoma Society, the Michigan
Ophthalmological Society as well as a Past Chair of the American Board of Ophthalmology.
R. K. Parrish II, Miami, FL
Richard K. Parrish II, MD, is Professor and Associate Dean for Graduate Medical Education at the University of Miami Miller School
of Medicine in Miami, Florida. He also serves as Chairman of the Graduate Medical Education Committee and as the Designated Institutional
Representative for the Jackson Health System/Jackson Memorial Hospital. Dr. Parrish earned his MD from the Indiana University School
of Medicine, served his internship at the University of Alabama School of Medicine in Birmingham, and completed a residency at Willis
Eye Hospital in Philadelphia, Pennsylvania. He finished a clinical and research glaucoma fellowship at Bascom Palmer Eye Institute/Anne
Bates Leach Eye Hospital at the University of Miami Miller School of Medicine.
Dr Parrish is a member of the American Academy of
Ophthalmology, the American Ophthalmological Society, and the Florida Ophthalmological Society. He has served as an Associate Editor
for the Brief Reports section of the American Journal of Ophthalmology since 2002 and edited Bascom Palmer Eye Institute's Atlas of Ophthalmology.
This year he will assume the editorship of the Transactions of the American Ophthalmological Society. He is the American Glaucoma Society
Councilor to the American Academy of Ophthalmology.
Dr Parrish is principal investigator of the National Eye Institute sponsored
Optic Disc Reading Center for the Collaborative Initial Glaucoma Treatment Study (CIGTS) and is a Vice Chairman of Ocular Hypertension
Treatment Study (OHTS) and Co-Principal Investigator of the OHTS Optic Disc Reading Center.
A. L. Coleman, Los Angeles, CA
Anne Louise Coleman, MD, PhD is a Professor of Ophthalmology in the Jules Stein Eye Institute
of the David Geffen School of Medicine at UCLA as well as Professor of Epidemiology in the UCLA School of Public Health. She holds the
Frances and Ray Stark Endowed Chair at UCLA and is Director of the Jules Stein Eye Institute Mobile Eye Clinic. Currently she serves
as past President of Women in Ophthalmology, and she has received the Senior Achievement Award (2004) and Secretariat Award (2003, 2004)
from the American Academy of Ophthalmology (AAO).
Dr. Coleman received a BA in Chemistry from Duke University and an MD from the Medical
College of Virginia, where she earned membership in the Alpha Omega Alpha honor society. After a surgical internship at the Medical College
of Virginia, she went to the University of Illinois at Chicago for her residency training in ophthalmology, followed by fellowship training
in glaucoma at the Wilmer Eye Institute, Johns Hopkins University. She received a PhD in Epidemiology from UCLA in 1997, where she earned
membership in the Delta Omega honor society.
Dr. Coleman's research is focused on the diagnosis, treatment, and societal impact of
glaucoma, cataracts, and age-related macular degeneration (AMD), including the study of lifestyle limitations imposed on patients with
these eye diseases. Ongoing research projects include participation as an investigator in the Ocular Hypertension Treatment Study; a
population-based study of the prevalence of glaucoma and AMD in Thessaloniki, Greece; geographic variation in diagnostic procedures and
clinical outcomes among patients with eye diseases in the Medicare population; and the possible association between hip fractures from
falls and impaired vision from glaucoma, cataracts, and AMD. Dr. Coleman is currently Principal Investigator of a collaborative multi-site
study funded by the National Eye Institute on the incidence of AMD in elderly women.
With activities ranging from local to national
and international organizations, Dr. Coleman has made numerous professional contributions. She is currently a consultant of the U.S.
Food and Drug Administration Ophthalmic Devices Panel, and she chairs the Glaucoma Subcommittee of the National Eye Health Education
Program of the National Institutes of Health. Since 2003, she has served as Executive Editor of Glaucoma for the American Journal
of Ophthalmology. She is Chair of the Glaucoma Panel for the Knowledge Base of the AAO, having previously served as Chair of the
AAO Interspecialty Education Committee and as a member of the Health Policy Committee and the Task Force on Aging of the AAO. Other professional
activities include service as President of the Los Angeles Society of Ophthalmology in 2003, current service as Chair of the Nominating
Committee of the American Glaucoma Society, and current membership in the American Academy of Ophthalmology EyeCare America Glaucoma
Society. She is the co-editor (with Dr. John Morrison) of the text "Management of Cataracts and Glaucoma", published in 2004.
J. H. Kempen, Philadelphia, PA
John H. Kempen, MD, PhD, MPH, MHS , is Director of the Ocular Inflammation Service
and of Ophthalmic Epidemiology at the Scheie Eye Institute, Department of Ophthalmology, the University of Pennsylvania. He also serves
as a Senior Scholar in the University of Pennsylvania Center for Clinical Epidemiology and Biostatistics. He is also serves as a member
of the Office of AIDS Research Advisory Council of the National Institutes of Health.
Dr. Kempen received his undergraduate training
at Stanford University, and completed his M.D. at the University of California, San Diego. His Ph.D. (Epidemiology), M.P.H. (International
Health), and M.H.S. (Biostatistics) were completed at the Johns Hopkins University School of Hygiene and Public Health. He completed
an internship at Santa Clara Valley Medical Center (San Jose, CA), residency in Ophthalmology at the University of Washington, and clinical
fellowship in Uveitis and Clinical Immunology at the Wilmer Eye Institute. In addition, he completed research fellowships in Preventive
Ophthalmology and Clinical Trials at Johns Hopkins.
Dr. Kempen is an ophthalmic epidemiologist, with particular interest in ocular
inflammatory and infectious diseases. He has published extensively on ocular complications of AIDS, and directed the Johns Hopkins CMV
Retinitis Cohort Study from 1998-2005, which characterized the effects of highly active antiretroviral therapy on the clinical course
of cytomegalovirus retinitis. He conceived of, developed and currently chairs the Systemic Immunosuppressive Therapy for Eye Diseases
(SITE) Cohort Study, the first multicenter NIH-sponsored clinical research study in the field of ocular inflammatory diseases. He also
serves as Vice-Chair of the Multicenter Uveitis Steroid Treatment (MUST) Trial, an investigator-initiated international clinical trial
funded by the National Eye Institute. Completed work includes co-coordinating the Eye Diseases Prevalence Research Group. He is the founding
Director of the Ocular Inflammation Service of the Scheie Eye Institute, which serves as a referral center for the management of ocular
inflammatory diseases in Pennsylvania, New Jersey, Delaware, and adjacent states.
T. P. Margolis, San Francisco, CA
Todd P. Margolis MD, PhD.
Todd P. Margolis received his B.S. from Stanford
University in 1977. He subsequently received his PhD in Neuroscience and MD from UCSF in 1984. After internship in San Francisco, he
trained as a resident in ophthalmology at UCSF with subseqeunt subspecialty training in corneal and external diseases at the F. I. Proctor
Foundation. He then pursued postdoctoral research training on herpesvirus latency in the laboratory of Dr. Jack Stevens in the Department
of Microbiology and Immunology at UCLA. While at UCLA he also served as a visiting assistant professor at the Jule Stein Eye Institute.
Dr. Margolis joined the faculty of the F. I. Proctor Foundation and the Department of Ophthalmology at UCSF as an Assistant professor
in 1991. He was appointed Director of the F. I. Proctor Foundation and Professor of Ophthalmology in 1999. He is also Director of the
Ralph and Sophie Heintz Research Laboratory. The primary focus of this lab is to carry out research on the cellular and molecular mechanisms
that regulate the establishment and maintenance of latent neuronal infection with herpes simplex virus (HSV). Dr. Margolis' clinical
expertise is in the diagnosis and management of infectious and inflammatory eye disease, with a particular interest in ocular disease
due to the herpes viruses and ocular infections in immmune compromised hosts. His clinical research is aimed at understanding the pathogenic
mechanisms leading to atypical presentations of ocular infections.
J. C. McCann, Salt Lake City, UT
John McCann was born in Iowa and a graduate of the University of Iowa, where he completed medical
school and received a PhD in biophysics and physiology. Dr. McCann completed eye surgery training at the University of California San
Francisco. He did fellowship in plastic surgery fellowship at the University of Utah. Dr. McCann is Board Certified and a member of the
American Society of Ophthalmic Plastic and Reconstructive Surgeons.
He moved to the Los Angeles area in 1996 to take a position as
a full-time faculty member of the Jules Stein Eye Institute at UCLA. Dr. McCann served a Director of the Aesthetic Center at UCLA, co-director
of the Orbital Disease Center, and a preceptor for the ophthalmic plastics surgery center training program at UCLA. Dr. McCann also serves
as the Chief of Ophthalmology at one of UCLA's affiliated hospitals. In 2006 Dr. McCann relocated to enter into private practice at
The Center For Facial Appearances in Salt Lake City, Utah. He is the head of Ophthalmology at Salt Lake Regional Medical Center and
serves as a preceptor for the ASOPRS fellowship.
He lectures nationally and internationally on his research interest which include
development of new surgical techniques for patients with disorders of the eyelids and orbit. He is actively involved in Grave's disease
and Benign Essential Blepharospasm research and he also has a research interest in the use of software to improve ophthalmic patient
care. Dr. McCann limits his practice to surgical management of eyelids, orbit, lachrymal drainage system, and aesthetic surgery of the
face. His is particularly interested in cosmetic surgery of the eyelids, midface, and forehead.
N. J. Newman, Atlanta, GA
Dr. Nancy J. Newman is the Leo Delle Jolley Professor of Ophthalmology, Professor of Ophthalmology
and Neurology and Instructor in Neurological Surgery at the Emory University School of Medicine, where she serves as the Director of
Neuro- Ophthalmology. She also holds the academic position of Lecturer in Ophthalmology at the Harvard Medical School. She attended
Princeton University, the University of London on a Marshall Scholarship, and Harvard Medical School. She trained in Neurology at
the Massachusetts General Hospital and in Neuro-Ophthalmology at the Massachusetts Eye and Ear Infirmary. She is a Fellow of the American
Academy of Neurology and of the North American Neuro-Ophthalmology Society. She serves on the Editorial Boards of the American
Journal of Ophthalmology, the Journal of the Neurological Sciences and the Journal of Neuro-Ophthalmology. She has over 200
publications, including scientific articles, book chapters and books, including the primary textbook in Neuro- Ophthalmology, Walsh & Hoyt's Clinical Neuro- Ophthalmology, 5th Edition. Her main research interests include disorders of the optic nerve and mitochondrial
diseases. She also currently serves on the Board of Trustees of Princeton University.
R. J. Olson, Salt Lake City, UT
Randall J. Olson, MD, is the John A. Moran Presidential Professor and Chairman of the Department
of Ophthalmology and Visual Sciences at the University of Utah School of Medicine. He is also the Chief Executive Officer of the John
A. Moran Eye Center at the University of Utah. He received his MD degree from the University of Utah in 1973 and completed his residency
at UCLA in 1977. He then completed two fellowships in cornea/external disease at the University of Florida and LSU.
Dr. Olson
has, in particular, been involved with understanding complications and problems in association with cataract surgery, which is the most
common surgical procedure in the United States today and represents a substantial part of an average ophthalmologist's practice. His
key focus has been has been why intraocular lens designs are successful and how problems can be prevented. In assisting The David J.
Apple Center for Biodevices Research and its predecessor, The Center for Intraocular Lens Research, at the University of Utah, many quality
improvements and recalls of these lenses have occurred. Research in cataract removal technology has been another important interest.
He publishes and lectures widely on these subjects.
Doctor Olson has been Chair of Ophthalmology and Visual Sciences at the University
of Utah since June, 1979, when it was a one-person Division of Surgery. He has been the leader through the expansion into Departmental
status and was involved in the fundraising and creation of the John A. Moran Eye Center dedicated in 1993. Due to continued expansion
and size restriction, a second John A. Moran Eye Center was dedicated August 3, 2006 and represents 210,000 square feet, with over half
the building dedicated to lab space involved in ophthalmic research.
D. W. Parke II, Oklahoma City, OK
David W. Parke II, M.D. is President and Chief Executive Officer of the Dean A. McGee Eye Institute.
The McGee Eye Institute is one of the nation's largest facilities devoted solely to research, clinical care, and education in ophthalmology
and vision science. It has over 200 faculty and staff, five locations, and ranks in the top twenty institutions nationally in terms
of National Eye Institute research grant support. Dr. Parke is also Edward L. Gaylord Professor and Chair of the Department of Ophthalmology
in the University of Oklahoma College of Medicine.
A graduate of Stanford University and an honors graduate of Baylor College of
Medicine, Dr. Parke completed residency training at Baylor College of Medicine, serving as Chief Resident. He then completed two years
of fellowship training in diseases and surgery of the retina and vitreous. His professional activities have focused on that subspecialty
and on medical education and biomedical organizational leadership and development.
Dr. Parke is a fellow of the American Academy
of Ophthalmology and received its Honor Award in 1989 and its Senior Achievement Award in 1998. He has maintained a particular interest
and expertise in medical education, serving as Chairman of the Academy's Resident and Fellow Education Committee, Ophthalmologists-in-Training
Committee, and Interprofessional Education Committee. In 2001 Dr. Parke was elected Senior Secretary for Ophthalmic Practice and has
served on the Academy Board of Trustees since 2000.
Dr. Parke's other active medical leadership positions include Past President
of the Association of University Professors of Ophthalmology. He is a Board Director of the Oklahoma Academy of Ophthalmology; of a
statewide multispecialty IPA; and of a multistate PPO. He is also on the Board of Directors of the Ophthalmic Mutual Insurance Company
(OMIC) and of Medem, Inc.
Dr. Parke serves on the Editorial Board of two ophthalmic journals, including as Executive Editor of
the American Journal of Ophthalmology and has received numerous biomedical research grants. He has served as an Associate Examiner
for the American Board of Ophthalmology for over ten years, currently as a Mentor Examiner and is an active member of the American College
of Physician Executives. Dr. Parke lectures widely on topics in retina, professional development, and medical organizational leadership
and management. He is recognized in Who's Who in America and Best Doctors in America.
Community activities include past Board member
of the Greater Oklahoma City Chamber of Commerce and Oklahoma Economic Development Foundation. Dr. Parke is a member of the Board of
Trustees of the Oklahoma Health Center Foundation and of the Presbyterian Health Foundation. He serves as Vice-Chair of the Board of
Trustees of Casady School.
J. S. Pepose, St. Louis, MO
Jay S. Pepose, M.D., Ph.D.
Dr. Pepose is a subspecialist in refractive surgery,
cornea and external diseases. He is Director of Pepose Vision Institute, Clinical Professor of Ophthalmology and Visual Sciences at Washington
University and Medical Director of the Mid-America Eye and Tissue Bank in St. Louis, Missouri. He is also Director of the Midwest Cornea
Research Foundation. Dr. Pepose earned his Ph.D. in Microbiology/Immunology and M.D. at UCLA; completed residency training at The Wilmer
Institute, The Johns Hopkins Hospital; and fellowship training at Georgetown University Medical Center. He is the recipient of the Cogan
Award from ARVO and the Honor Award from the American Academy of Ophthalmology, and has received research support from both public and
private sources, including the National Eye Institute. He has published extensively and lectured nationally and internationally on various
aspects of refractive surgery, external diseases and eye banking, and is senior co-editor of the volume Ocular Infections and Immunity.
He is currently involved in clinical trials of presbyopia surgery and various aspects of lamellar laser surgery.
P. Sternberg, Jr., Nashville, TN
Paul Sternberg. Jr. is currently the Thomas M. Aaberg Professor of Ophthalmology and Director
of the Vitreoretinal Service at the Emory University Eye Center, where he has been a member of the faculty since 1985. He is graduate
of Harvard College and University of Chicago Pritzker School of Medicine. He received his ophthalmology training at the Wilmer Eye Institute
and was a vitreoretinal fellow at the Duke University Eye Center. Dr. Sternberg's clinical interests include age-related macular degeneration,
retinopathy of prematurity and ocular trauma. He has been an active participant in multicenter clinical trials, including MPS, COMS,
EVS, AREDS, and CAPT, and is Vice Chairman of the ongoing Submacular Surgery Trials. In addition, he maintains an active research laboratory
studying the pathogenesis of ARMD, supported by the National Eye Institute, Foundation Fighting Blindness, Research to Prevent Blindness,
and the Macula Society. Dr. Sternberg has authored or co-authored over 150 scientific articles and 25 book chapters. In addition to
the AJO, he has served on the editorial board for Investigative Ophthalmology. He has also chaired the NIH Visual Sciences
C Study Section for Retinal and Choroidal Diseases.
E. I. Traboulsi, Cleveland, OH
Elias I. Traboulsi, M.D. is the Head of the Department of Pediatric Ophthalmology and the
Director of the Center for Genetic Eye Diseases at The Cleveland Clinic Cole Eye Institute. He is Professor of Ophthalmology at Ohio
State University and Director of the ophthalmology residency program at the Cleveland Clinic Foundation. He is the President of The
International Society for Genetic Eye Disease and the Editor-In-Chief of Ophthalmic Genetics. He also serves on the editorial board
of the American Journal of Ophthalmology and of Contemporary Ophthalmology. He is a frequent guest speaker at national and international
meetings, and the author of more than 200 scientific articles and book chapters. His book on "Genetic Diseases of the Eye" published
by Oxford Univeristy Press in 1999 is one of the major references on this topic.
His clinical and research interests include the
management and genetics of strabismus and congenital cataracts, and the nosology of ophthalmic and general medical genetic disorders
and syndromes. He has special interest in ocular developmental biology and ocular malformations, retinoblastoma, retinal dystrophies,
childhood glaucoma and other common and rare ocular diseases of children.
M. E. Wilson, Charleston, SC
M. Edward Wilson, Jr., M.D. Pierre G. Jenkins Professor and Chairman
Department of Ophthlamology Medical University of SC Charleston, SC
Dr. Wilson
was born and raised in Charleston, South Carolina. His M.D. degree is from the Medical University of South Carolina. After an internship
and residency in ophthalmology at the National Naval Medical Center in Bethesda, Maryland, Dr. Wilson served a one-year fellowship in
pediatric ophthalmology and strabismus with Dr. Marshall Parks.
Dr. Wilson is currently the Pierre G. Jenkins Professor and Chairman
of the Department of Ophthalmology and the Director of the Albert Florens Storm Eye Institute at the Medical University of South Carolina
in Charleston. Dr. Wilson has received an honor award from AAPO&S and an achievement award from the American Academy of Ophthalmology.
Dr. Wilson is also the Immediate Past President of the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) and is
the Immediate Past Chairman of the American Academy of Ophthalmology's Basic and Clinical Science Course Committee responsible for Book
6 on Pediatric Ophthalmology and Strabismus.
Dr. Wilson's research interests include surgical technique and IOL design for use in
the treatment of pediatric cataracts, as well as the full range of strabismus in children and adults, especially the dissociated strabismus
complex.
Dr. Wilson has given more than 350 invited presentations at national and international conferences including six named
lectures. He has published over 100 scientific papers and book chapters on a wide variety of subjects.
W. L. M. Alward, Iowa City, IA
Wallace L.M. Alward, M.D.
A Canadian by birth, Dr. Alward grew up and received his education in Ohio at Kenyon College and
The Ohio State University College of Medicine. After a surgical internship at the University of Pittsburgh he traveled to Alaska to fulfill
a two- year commitment to the U.S. Public Health Service. Dr. Alward extended his stay in Alaska to six years; four with the Indian Health
Service and two with the Arctic Laboratory of the Centers for Disease Control. While practicing general medicine in Eskimo villages,
Dr. Alward became interested in diseases of the eye and elected to specialize in ophthalmology. He performed his residency at the University
of Louisville and subsequently a glaucoma fellowship at Bascom Palmer Eye Institute of the University of Miami followed. In 1987, upon
completion of his training, he became the director of the Glaucoma Service at the University of Iowa. He currently holds the rank of
professor and vice-chairman.
Dr Alward's CV includes approximately 100 peer-reviewed publications highlighted by the initial reports
of three glaucoma-causing genes - myocilin, PITX2 and FOXC1. Besides molecular genetics he has a research interest in pigmentary glaucoma,
normal tension glaucoma, gonioscopy, and glaucoma filtering surgery. He has authored two textbooks, one of which was listed as one of
the 100 important ophthalmology books of the 20th century. Dr Alward is on the editorial boards of the American Journal of Ophthalmology,
The Journal of Glaucoma and the International Glaucoma Review. He reviews manuscripts for many other publications including the New England
Journal of Medicine and Lancet.
R. Belfort, Jr., São Paulo, Brazil
RUBENS BELFORT JR., M.D. Ph.D. Professor and Chairman, Department of Ophthalmology
Federal University of São Paulo (Escola Paulista de Medicina-Hospital São Paulo) SÃO
PAULO - BRAZIL
Head Professor of Ophthalmology, Escola Paulista de Medicina/Federal University of Sao Paulo, Brazil.
Doctor Degree in Ophthalmology,1981. Ph.D. in Immunology,1985. MBA,1996.
Member of the Academia Ophtalmologica Internationalis,
Brazilian Academy of Sciences and National Academy of Medicine, Brazil.
President Pan-American Association of Ophthalmology (2001-2203)
The World Congress of Ophthalmology, Brazil, (2006).
Medical Degree and Ophthalmology Residency at the Hospital São Paulo
(Federal University of Sao Paulo).
Fellowship at the Proctor Foundation-University of California, SF
Visiting Scientist as a Fogarty
Fellow at the National Eye Institute (NEI-NIH),1990.
More than 160 peer-reviewed scientific publications in Brazil and over 92 in
foreign Journals. Many review articles, and book chapters.
Edited and co-authored 9 Ophthalmological Books in English, Portuguese
and Spanish. Conferences in 24 countries.
National and International Awards including the American Academy of Ophthalmology's
Honor Award (1993), Brazilian Council of Ophthalmology Award ( 1995), Pan-American Medal for Distinguished Services(1997)
American Journal of Ophthalmology Lecture (1990) Jackson Memorial Lecture, (AAO), (1998).
Former Editor in Chief of
the Brazilian Archives of Ophthalmology,1979-2000.
President of the World Uveitis Symposium,1988, President of the Pan-American
Congress of Ophthalmology in 1989. President Brazilian Congress of Ophthalmology 2001
Member of many Ophthalmological Societies
such as the Brazilian Council of Ophthalmology, AAO,ARVO, ISRS, and the International Uveitis Study Group.
Member of the International
Editorial Board of many prestigious Journals such as the American Journal of Ophthalmology.
V. Biousse, Atlanta, GA
Valérie Biousse, MD
Valérie Biousse received her medical degree from the University
of Paris VI (Pitié-Salpétriere) in Paris, France. She also holds a masters of science from the same university. She trained
as an academic neurologist in Paris, where she also completed a stroke fellowship. She came to Emory for a clinical research fellowship
in neuro-ophthalmology and subsequently completed an internal medicine internship and an ophthalmology residency at Emory University
(Atlanta, GA). Dr Biousse joined the department of Neurology in 1998, and the department of Ophthalmology at Emory University in 2002.
She currently holds the rank of Associate Professor of Ophthalmology and Neurology.
The author or coauthor of more than 100 publications
and more than 50 teaching articles and book chapters, Dr Biousse's most notable work is on ocular manifestations of cerebrovascular disease.
She is one of the editors for the 6th edition of the major textbook in neuro-ophthalmology, the "Walsh & Hoyt Clinical Neuro-Ophthalmology".
She is serving on the editorial boards of the American Journal of Ophthalmology and the Journal of Neuro-Ophthalmology. She
is an active member of the American Academy of Neurology, the American Neurologic Association, the American Heart Association, the American
Academy of Ophthalmology, the North American Neuro-ophthalmology Society, the International Neuro-Ophthalmology Society, the French Society
of Neurology and the French Society of Stroke.
M. S. Blumenkranz, Stanford, CA
Mark S. Blumenkranz, M.D., Professor and Chairman of the Department of Ophthalmology, Stanford University
School of Medicine. Dr. Blumenkranz is a graduate of Brown University where he received his Baccalaureate, Master of Medical Science
in Biochemical Pharmacology and M.D. degrees. He completed a Residency in Ophthalmology at Stanford and a Fellowship in Vitreoretinal
Diseases at the Bascom Palmer Eye Institute where he served on the faculty for an additional five years. Dr. Blumenkranz was the founder
of the Vitreoretinal Fellowship Programs at the Kresge Eye Institute and William Beaumont Hospital where he was also Director of Vitreoretinal
Surgery from 1985 to 1992. In 1992, Dr. Blumenkranz returned to Stanford where he served as the Director of the Retinal Service prior
to assuming the Chairmanship of the Department in 1997. Dr. Blumenkranz's areas of expertise include the medical and surgical treatment
of complex forms of retinal detachment and macular diseases including diabetic retinopathy, age-related macular degeneration and vitreomacular
tractional syndromes. He has made contributions in the development of new surgical techniques, new pharmacologic therapies and a variety
of disorders. He is a frequent lecturer throughout the world and has published more than 100 peer-reviewed articles and book chapters
on these topics. He has been a member of the Editorial Board of Ophthalmology, Retina, Graefe's Archives for Ophthalmology, Ophthalmology
Times, and the American Journal of Ophthalmology. He serves on numerous advisory boards as well as the Corporation of Brown
University. He is a recipient of the Senior Honor Award for the American Academy of Ophthalmology, a Research to Prevent Blindness Special
Manpower Award, and the Rosenthal Award in Visual Sciences amongst others. He is married to Recia Kott Blumenkranz, M.D., and has three
children. He resides in Portola Valley, and in his spare time enjoys tennis, fitness, sailing, viticulture, reading and music.
L. B. Cantor, Indianapolis, IN
Louis B. Cantor, M.D. is a Professor at the Indiana University School of Medicine and Director of the
Glaucoma Service. He completed his undergraduate and graduate medical education at Indiana University and was an Ophthalmology Resident
at Indiana University, graduating in 1984. In 1985, he completed his glaucoma fellowship at Wills Eye Hospital in Philadelphia under
the direction of George L. Spaeth, M.D. Since 1996 Dr. Cantor has served as the Ophthalmology Residency Program Director at the Indiana
University School of Medicine. Dr. Cantor is an attending physician at several Indianapolis area hospitals, including Clarian
Health Systems, Indiana University and Riley Hospitals, Wishard Memorial Hospital, and the Roudebush Veterans Administration Hospital.
Dr. Cantor, is a member and past President of the Indiana Academy of Ophthalmology, a past President of the Spaeth Glaucoma Fellow Society,
past President of the Indianapolis Ophthalmological Society, past Treasurer of the American Glaucoma Society, current Chairman of the
Medical Advisory Board for Prevent Blindness Indiana, and President of the Glaucoma Research and Education Foundation, Inc.
Dr.
Cantor serves on the Editorial Review Board for the American Journal of Ophthalmology and has been an invited reviewer for Ophthalmology, American Journal of Ophthalmology, Archives of Ophthalmology, Clinical Therapeutics, Glaucoma, and other
medical journals.
Dr. Cantor is a frequent invited lecturer and has presented named lectureships in Indianapolis and Chicago. He
is a recipient of multiple grants and has published over 100 abstracts and 70 peer reviewed publications.
J. Caprioli, Los Angeles, CA
Dr. Caprioli received undergraduate and medical degrees from the State University of New York, followed
by surgical internship and ophthalmology residency at Yale. Dr. Caprioli served as a glaucoma fellow with Dr. George Spaeth at Wills
Eye Hospital in 1983-1984. Dr. Caprioli was appointed to the full time faculty at Yale in 1984, and served as Director of the Glaucoma
Section until 1997, having achieved the rank of Professor in 1993.
Dr. Caprioli has been the recipient of numerous awards, including
the Jules Francois Prize of the Belgian Ophthalmological Society, the Alcon Research Institute Award, the Honor Award of the American
Academy of Ophthalmology, the Senior Achievement Award of the American Academy of Ophthalmology, the Wasserman Merit Award and Physician
Scientist Award from Research to Prevent Blindness. He has presented numerous guest lectures and named lectures internationally, including
the prestigious annual Edmund B. Spaeth Oration at the Philadelphia College of Physicians. In July 1997, he was named the Frances and
Ray Stark Professor of Ophthalmology and Chief, Glaucoma Division at UCLA's Jules Stein Eye Institute.
He has extensive experience
in all aspects of glaucoma diagnosis and treatment, anterior segment surgery and laser techniques. Dr. Caprioli has trained numerous
clinical and research fellows, many of whom now hold full-time faculty positions in academic centers worldwide.
D. Coats, Houston, TX
Dr. David K. Coats received his medical degree from Texas Tech University School of Medicine, followed
by residency at Storm Eye Institute at the Medical University of South Carolina. He then completed a fellowship in pediatric ophthalmology
and adult strabismus at Indiana University in Indianapolis, Indiana. He joined the faculty of the Cullen Eye Institute at Baylor College
of Medicine in 1996, where he is currently Professor of Ophthalmology and Pediatrics.
Dr. Coats has published more than 80 peer-reviewed
articles and is co-author of the textbook Strabismus Surgery and its Complications. He serves on the Editorial Board for the American Journal of Ophthalmology, Journal of Pediatric Ophthalmology and Strabismus, and Medscape Ophthalmology.
Dr. Coats is involved in education with the American Academy of Ophthalmology as the Chairman of the Ophthalmologic Knowledge and Assessment
Committee and as Chairman of the Pediatric Subspeciality Information Team. He is Chief of Ophthalmology at Texas Children's Hospital
and directs teaching activities for medical students, residents, and fellows in the Section of Pediatric Ophthalmology at Baylor College
of Medicine.
N. Congdon, Hong Kong, China
J. L. Davis, Miami, FL
S. Fekrat, Durham, NC
H. W. Flynn, Jr., Miami, FL
Harry W. Flynn, Jr., MD received a Bachelor of Science Degree at Wake Forest University in 1967
and his Doctor of Medicine Degree at the University of Virginia, School of Medicine in 1971. After an internship at the Pacific Medical
Center in San Francisco, Dr. Flynn completed his residency training in Ophthalmology at the University of Virginia, School of Medicine.
Following a Retina Fellowship at Pacific Medical Center in San Francisco, Dr. Flynn had two years of active duty in the United States
Army at the Brook Army Medical Center in San Antonio (1976-1978). Dr. Flynn joined the faculty at the Bascom Palmer Eye Institute in
September 1978. Dr. Flynn is currently holds the J. Donald M. Gass MD Distinguished Chair in Ophthalmology at the University of Miami
School of Medicine.
Dr. Flynn has been author or co-author of more than 240 publications as well as 45 book chapters. He has edited
or co-edited four books including Diabetes and Ocular Disease: Past, Current, and Future Therapies and Vitreoretinal Disease: The Essentials.
Dr. Flynn has held numerous administrative positions including President: The Vitreous Society (192-1993), President: The Miami Ophthalmological
Society (1999) and President: The Retina Society (2002-2003). Dr. Flynn has served as Senior Editor for Section 12 (Retina) of the Basic
and Clinical Science Course for the American Academy of Ophthalmology (1999-2002). He has also served as Co-Director of the Retina Subspecialty
Day for the American Academy of Ophthalmology (1998-199). He serves on the Editorial Board of numerous journals including the American
Journal of Ophthalmology, Retina, Ophthalmic Surgery and Lasers, and Evidence Based Ophthalmology.
D. S. Greenfield, Miami, FL
Dr. Greenfield is Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami Miller
School of Medicine, Miami, Florida. He earned his medical degree from the New York University School of Medicine in 1990 and completed
his residency at the New England Eye Center, Tufts University School of Medicine, Boston, in 1994. Dr. Greenfield completed a 1994-5
Heed Fellowship in Glaucoma and a 1995 Heed-Knapp Fellowship in Neuro-Ophthalmology at the Bascom Palmer Eye Institute, University of
Miami School of Medicine. He joined The New York Eye & Ear Infirmary in 1996 as Clinical Assistant Professor of Ophthalmology and Neurology.
Dr. Greenfield is co-founder of the International Society for Imaging in the Eye (ISIE) and is a member of the editorial boards of American
Journal of Ophthalmology, Journal of Glaucoma, and Ophthalmic Surgery Lasers and Imaging. He currently serves as chair of the American
Glaucoma Society Bylaws and Strategic Planning Committee, and is a member of the AGS Scientific Program Committee, the AAO Glaucoma Subspecialty
Day Committee and Technology Assessment Committee, and the Glaucoma Education Committee of EyeCare America. Dr. Greenfield has served
as Co-Chairman of the Glaucoma Subspecialty Day of the American Academy of Ophthalmology (2003-4), and was awarded the 2003 American
Academy of Ophthalmology Achievement Award. His research interests include optic disc and retinal nerve fiber imaging in glaucoma, bleb-related
ocular infection, normal-tension glaucoma, and complex glaucoma filtration surgery. He is the recipient of an NEI consortium grant studying
advanced imaging technology in glaucoma. He has lectured nationally and internationally on these topics and has published over 150 original
scientific papers, abstracts and book chapters.
J. A. Haller, Baltimore, MD
Dr. Julia A. Haller Dr. Julia A. Haller was educated at the Bryn Mawr School in Baltimore, Princeton
University, and Harvard Medical School. She interned in the Halsted surgery program at Johns Hopkins Hospital and then spent a year with
Dr. Frederick A. Jakobiec as a fellow in ocular pathology at Manhattan Eye, Ear and Throat Hospital and Cornell Medical Center. She
was an ophthalmology resident at the Wilmer Eye Institute at Johns Hopkins Hospital, 1982-1985, and then stayed at Wilmer for her retina
fellowship with Ronald G. Michels, M.D. She became the first female Chief Resident at the Wilmer Eye Institute at Johns Hopkins in
1986. She joined the faculty as Assistant Professor at Johns Hopkins in 1987, and became the inaugural Katharine Graham Professor of
Ophthalmology in 2002. In May of 2006, she was installed as the inaugural Robert Bond Welch, M.D. Professor of Ophthlamology.
Her
honors include the Bryn Mawr School scholarship award for valedictorian in 1972, National Merit Scholarship 1972, her A.B. in philosophy Magna cum laude, Alpha Omega Alpha, a Heed Foundation Fellowship grant, the American Academy of Ophthalmology Honor Award, the
Rolex Achievement Award, the Vitreous Society Honor Award, the American Academy of Ophthalmology Senior Achievement Award, the Vitreous
Society Senior Honor Award, and the Crystal Apple Award of the Young Physicians group of the American Society of Retina Specialists for
teaching and mentorship.
Dr. Haller has published over 180 papers in the peer reviewed literature as well as 15 book chapters. She
has been a visiting professor and lecturer all over the world, with a particular interest in the repair of complicated retinal detachments,
management of complications of anterior segment surgery, posterior segment inflammatory diseases, diabetic retinopathy and age-related
macular degeneration.
She is the principal investigator or co-investigator on numerous grants dealing with treatment of cystoid macular
edema, age-related macular degeneration, submacular surgery, diabetic retinopathy, retinopathy of prematurity, retinal venous occlusive
disease and retinal infectious disease. She directs the Wilmer Retina fellowship program in vitreoretinal surgery.
Dr. Haller is
an executive editor for the American Journal of Ophthalmology, and serves on the Editorial Boards of RETINA, the Wilmer Retina
Update, the Vitreous Society Journal, Evidence-Based Eye Care, The Johns Hopkins Women=s Health Book, Retina Physician, and the Johns
Hopkins Medical News magazine.
She is Program Chair and President Elect of the American Society of Retina Specialists and a member
of the Executive Committee of the Retina Society. She is the Retina representative on the American Academy of Ophthalmology Program
Committee.
She is a member of the Board of Trustees of the Bryn Mawr School in Baltimore, Maryland, on the volunteer physician staff
at the Joseph Richey Hospice and has five children with her husband, John D. Gottsch, M.D.
N. M. Holekamp, St. Louis, MO
Nancy Melberg Holekamp, MD is an Associate Professor of Clinical Ophthalmology and Visual Sciences at
the Washington University School of Medicine in St. Louis, Missouri. She is also a partner in the Barnes Retina Institute. Dr. Holekamp
received her undergraduate Bachelor of Arts degree from Wellesley College Summa cum Laude. She received her Medical Degree from the
Johns Hopkins School of Medicine. Dr. Holekamp completed an internship in internal medicine and a residency in ophthalmology at the
Washington University School of Medicine. Her fellowship training in vitreoretinal surgery was with the Retina Consultants (now the
Barnes Retina Institute) in St. Louis.
Dr. Holekamp is actively involved in clinical research, having been principal investigator
or sub-investigator in more than 10 national clinical trials dealing with age-related macular degeneration, retinal vascular occlusion,
and diabetic retinopathy. Her efforts in research have resulted in more than 40 peer-reviewed publications, more than 10 book chapters,
and numerous speaking invitations both nationally and internationally. She is a member of the major subspecialty societies, including
membership on the Executive Committee of the Macula Society. She acts as a reviewer for four major ophthalmology journals and as a consultant
to two ophthalmic pharmaceutical companies. After 6 years on the American Academy of Ophthalmology Ethics Committee, she has developed
an interested in medical ethics.
D. A. Jabs, New York, NY
Douglas A. Jabs, M.D., M.B.A. is The Alan C. Woods Professor of Ophthalmology and a Professor of Medicine at the Johns Hopkins
University School of Medicine and Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. He is the Director
of the Division of Ocular Immunology. He received his undergraduate degree from Dartmouth College and his M.D. from the Johns Hopkins
University School of Medicine. He has done an internship in Internal Medicine at Cornell Medical Center, New York Hospital, a residency
in Internal Medicine at the Johns Hopkins Hospital, a residency in Ophthalmology at the Wilmer Eye Institute, and a fellowship in Rheumatology
at The Johns Hopkins Medical Institutions. In 1984, he joined the faculty at The Johns Hopkins University School of Medicine and was
promoted to Professor in both Ophthalmology and Medicine in 1993. He received a Masters of Science in Business from the John Hopkins
University School of Continuing Studies in 1998, and in 2000, received a Masters in Business Administration from the Johns Hopkins University
School of Professional Studies in Business and Education. Dr. Jabs has been recipient of such honors and awards as the Research to Prevent
Blindness Olga Keith Wiess Scholar Award, the Research to Prevent Blindness Lew R. Wasserman Merit Award, the Research to Prevent Blindness
Senior Scientific Investigator, the American Academy of Ophthalmology Honor Award, and the Ethel Baxter Award for Excellence in Research
from the Sjogren's Syndrome Foundation. He was President of the American Uveitis Society for 2000-2002. He served on the National Eye
Institute's Visual Sciences A Study Section from 1994 to 1998 and currently is on the National Eye Institute Intramural Program Data
and Safety Monitoring Committee. He has held funding from the National Eye Institute since 1986. He is the Chairman of the Studies of
Ocular Complications of AIDS Research Group, a clinical trials program which has been in existence since 1988, has conducted five randomized,
multicenter, controlled, clinical trials on the treatment of cytomegalovirus retinitis and chairs an ongoing multicenter, prospective,
cohort study of patients with AIDS for ocular complications and visual outcomes. His other research interests include the immunopathogenesis
of autoimmune ocular disease, the epidemiology, molecular biology and clinical consequences of resistant cytomegalovirus among patients
being treated for cytomegalovirus retinitis, and the treatment of uveitis. He has authored or coauthored over 145 publications and 36
book chapters. His areas of expertise include the treatment of uveitis and other ophthalmic inflammatory disorders, the ocular complications
of autoimmune disease, of immune deficiency and of immune suppression, and cytomegalovirus retinitis.
A. Kampik, Munich, Germany Anselm Kampik M.D. Professor & Chairman Augenklinik der Universität München
Klinikum Innenstadt Mathildenstraβe 8 Tel.: +49-89-5160-3800 Fax: +49-89-5160-4778
1968-1974: Medical School at Ludwig-Maximilians-Universität München 1974: Medical Board examine 1974: Promotion
Dr.med.: Thesis on Retinal detachment 1974-1975: House officer at Hospitals in Munich 1975-1979: Resident at Augenklinik der
Universitat Munchen, Germany 1979-1980: Fellowship in Ophthalmology supported by Deutschen Forschungs-gemeinschaft at The Wilmer
Ophthalmological Institute, The Johns Hopkins Hospital, Baltimore, Maryland, USA: Working fields: Eye-Pathology, especially of vitreo-retinal
diseases, glaucoma, and the cornea 1981-1987: Faculty member at the Augenklinik der Ludwig-Maximilians-Universität München 1981: Habilitation: Dr. med. habil. fur Augenheilkunde with thesis on: "Epiretinal and vitreous membranes" 1982: Appointment:
Privatdozent fur Augenheilkunde 1985: Appointment as Associate Professor in Ophthalmology at Ludwig-Maximilians-Universität
München 1987: Appointment as Professor and Chairman of the Department of Ophthalmology at the Julius-Maximilians-Universität
Wärzburg succeeding Prof. Dr.Dr.h.c. W. Leydhecker 1987-1993: Professor & Chairman Augenklinik der Universität Wurzburg 1993: Appointment as Professor and Chairman of the Department of Ophthalmology at the Ludwig-Maximilians-Universitat Munchen succeeding
Prof. Dr. O.-E. Lund since 1.10.93 Professor & Chairman: Augenklinik der Universitat Munchen, Germany
Main Areas of Research and
Interest: Eye Pathology, Medical and Surgical Retina; Cell biology of the retina
Member of • Deutsche Ophthalmologische
Gesellschaft (DOG) • Berufsverband der Augenarzte Deutschlands (BVA) • Association for Research in Vision and Ophthalmology
(ARVO ) • American Academy of Ophthalmology • Club Jules Gonin • Retinologische Gesellschaft (German Retina
Society) • Deutschsprachige Ges. fur Intraokularlinsenimplantation (DGII) • Initiativgruppe zur Fruherkennung der diabetischen
Retinopathie (IfDA)
Functions: • Member of the Board: Deutsche Ophthalmologische Gesellschaft (DOG) Vice President (1995/1996) President (1996/1997) Executive Vice President (Generalsekretar) (1999 - 2006) • Vice President: Retinologische Gesellschaft
(1992-2000)
Chairman of the Advisory Board of the Retina Implant Project, sponsored by the German Ministry of Research
(BMBF) 1994-1999
Scientific Co-Organizer Essener Fortbildung fur Augenheilkunde (EFA) 1987 - 2000 and its succeeding Congress "Augenarztliche Akademie Deutschland" (AAD) since 2000
Member of the editorial board of
• Der Ophthalmologe since
1988 • Zeitschrift fur praktische Augenheilkunde since 1988 • Munchener Medizinische Wochenschrift since 1994 •
Investigative Ophthalmology and Visual Science (IOVS) since 1996 • Retina since 2002 • European Journal of Ophthalmology
since 2002 • American Journal of Ophthalmology since 2003
Publications:
medline-listed international scientific
journals: 174 publications Review articles: 35 publications Editor of 12 books and monographs
A. G. Lee, Iowa City, IA
Andrew G. Lee, M.D. is a graduate of the University of Virginia School of Medicine in 1989. He completed
his ophthalmology residency and was the chief resident at Baylor College of Medicine in Houston, Texas from 1990-1993. Following residency,
Dr. Lee completed a fellowship in neuro-ophthalmology at the Wilmer Eye Institute and was a post-doctoral Fight for Sight fellow at the
Johns Hopkins Hospital in Baltimore, Maryland from 1993-1994. He was formerly an Associate Professor at Baylor College of Medicine and
Adjunct Associate Professor at the M.D. Anderson Cancer Center in Houston from 1994-2000. Dr. Lee is currently Associate Professor of
Ophthalmology, Neurology, and Neurosurgery at the University of Iowa Hospitals and Clinics. He has published over 160 peer reviewed articles
and 20 book chapters and has authored two textbooks in ophthalmology. He is listed in Best Doctors in America, received the Achievement
Award and the Secretariat Award from the American Academy of Ophthalmology, and was the 2001 recipient of the Charles Phelps Memorial
Award for Research and Education.
S. L. Mansberger, Portland, OR
Steven L. Mansberger, M.D., M.P.H. is an Assistant Scientist and Director of Ophthalmic Clinical
Trials for the Devers Eye Institute in Portland, Oregon. He is also the Director of Glaucoma Services at the Veterans Hospital, and
holds appointments at Oregon Health Science University (OHSU) as Adjunct Assistant Professor of Ophthalmology and Clinical Assistant
Professor of Public Health and Preventive Medicine.
Dr. Mansberger received his medical degree from Indiana University School of
Medicine. He completed an ophthalmology residency at Shiley Eye Center at the University of California, San Diego, and a glaucoma fellowship
at Devers Eye Institute. He also earned a Masters in Public Health degree (MPH-Biostatistics/Epidemiology) from OHSU.
Dr. Mansberger
has research grant support as principal investigator from the National Eye Institute, Center for Disease Control and Prevention, and
the American Glaucoma Society. He has authored over 40 journal articles, book chapters, and abstracts. He has won numerous awards
including a Heed Fellowship, The Robert Watske Ophthalmology Instructor of the Year, American Glaucoma Society Clinician-Scientist award,
among others. He is on the Editorial Board for Journal of Glaucoma and American Journal of Ophthalmology, and is an invited
reviewer for Archives of Ophthalmology, British Journal of Ophthalmology, Ophthalmology, Investigative Ophthalmology and Visual Science,
and Survey of Ophthalmology.
R. M. Menapace, Vienna, Austria
Rupert M. Menapace graduated in medicine "summa cum laude" in 1980 at the University of Vienna Medical
School and obtained full professorhip there in 1995. He is the founder and director of the Intraocular Lens Service at the Vienna Medical
University. Apart from cataract and intraocular lens implant surgery he has gained wide experience with trauma and reconstructive anterior
segment surgery. He has also worked in the field of surgical glaucoma, as well as irradiation and surgical treatment of intraocular melanoma
on which he wrote his professorial dissertation.
As by 2005, he published over 160 papers in peer-reviewed journals, and numerous
other papers and reviews for national and foreign journals, as well as several book chapters. He was vice president of the "German-speaking
Society of Intraocular Lens Implantation and Refractive Surgery" and has been a faculty member of numerous other national and international
professional organisations. He has regular been a main lecturer at the annual "Congress of German Ophthalmic Surgeons"(DOC). He held
a DOC "Ridley Lecture" and was awarded for the "Best German Ophthalmological Publication". He is listed in best-in-their-field list of
leading researchers of the german-speaking medicine (GaM) by the Society of Applied Meta-Research in Erlangen, Germany. He is Editorial
Board Member of the Journal of Cataract and Refractive Surgery since 1998 and is a regular reviewer for many other peer-reviewed journals.
His research is currently focusing on the reduction of after-cataract by improvements in intraocular lens the design and material,
capsular implants, and capsular surgery. Evaluation of current accommodative intraocular lenses and the search for alternative concepts
is another field of current interest.
K. Nishida, Osaka, Japan
Kohji Nishida, MD, PhD is Professor and Chairman of the Department of Ophthalmology and Visual Science
at Tohoku University Graduate School of Medicine in Sendai, Japan.
Dr. Nishida received his MD from Osaka University Medical School
in 1988, where he also completed his residency in Department of Ophthalmology with subsequent sub-speciality training on the cornea and
external diseases. In 1992, he joined the faculty at Kyoto Prefectural University of Medicine, while also continuing his activity in
corneal research at Osaka University Medical School. He received his PhD in 1997 from Osaka University Medical School and then undertook
research training as a research associate at the Salk Institute (San Diego, CA), where he studied stem cell biology from 1998-2000. In
2000, he then returned to Department of Ophthalmology, Osaka University Medical School as an Assistant Professor where he was promoted
to the position of Associate Professor in 2004. During this time Dr. Nishida performed clinical duties and teaching, as well as both
clinical and basic research regarding the cornea and external diseases. In 2005, he moved to his current position of Professor and Chairman
of the Department of Ophthalmology at Tohoku Graduate University of Medicine.
Dr. Nishida's clinical expertise is in the diagnosis
and management of corneal and external diseases, as well as refractive surgery. In particular he has a great interest in the surgical
management of ocular surface diseases. His current research interests include the pathogenesis of corneal diseases, the genetics of
corneal dystrophy, as well as stem cell biology and tissue engineering of the cornea. His longstanding interests in the treatment of
ocular surface diseases via reconstructive surgeries, has recently succeeded in the clinical application of a novel corneal bioengineering
technology developed by he and his colleagues. He received the Rhoto Award in 1997, Japanese Ophthalmology Society Award in 1998 and
ALCON Award in 2004. Dr. Nishida also serves on the organizing committee for a wide range of academic organizations including the Japanese
Ophthalmological Society, the Japan Cornea Society, the Japanese Society for Tissue Engineering, and the Japanese Society for Biomaterials.
He is a frequent guest speaker at national and international meetings and has published over100 peer-reviewed articles and over 50 book
chapters in the areas of corneal diseases and surgery, as well as corneal tissue engineering.
R. B. Nussenblatt, Bethesda, MD
Robert Burton Nussenblatt
In Brief: • Attending City College
of New York, SUNY Downstate (MD) • Training in both Internal Medicine and Ophthalmology • Attended the Advanced Management
Program of the Harvard Business School • Married to Rosine Rossignelly Nusenblatt. 3 children-Veronique, Valerie, Eric
Area
of interest: • Ocular Immunology with an emphasis on clinical immunology and translational research • Medical Ethics
and Clinical Trials • Has written a large number of protocols. Have interacted with the FDA with two studies as PI used for
NDAs
Established the Laboratory of Immunology, NEI, NIH. • Fellowship program in immunology. Clinical Fellowship
program in Ocular Immunology
As Scientific Director (1992-2001) • in Charge of 40 million dollar budget. Full authority
for scientific, budgetary, space and personnel matters • The spokesperson for the NEI for all intramural matters. Almost daily
interaction with the Deputy Director of Intramural Research, Dr. Gottesman. Constant interaction with other Scientific Directors. • Had been Clinical Director before becoming Scientific Director, thus covering the two major administrative positions for the intramural
program at the same time. • In charge of 37,000 sq ft of program space for laboratory space. 12,000 sq ft for clinical work. • Overall responsibility for many areas of science: genetics, Immunology including AIDS, Neuroscience, retinal biochemistry and
molecular biology, cataract research, diabetes and retinal vascular disorders, cornea and ocular embryology and development, glaucoma • At any one time some 300 individuals in the intramural program. About 160 are full time employees for science effort. •
Some 18 full time physicians see patients. Patients are seen under protocol in various clinical areas: dry eye, allergy, uveitis, AIDS,
retinal vascular disease, genetics, glaucoma, neuroophthalmology, ocular oncology and strabismus. • 12,000 outpatient visits
per year. • The Scientific Director is responsible for the mentoring program and assuring a positive scientific experience
for young investigators • Established core facilities for: gene therapy, confocal microscopy and in situ hybridization, and
microarray techniques. Groups emphasizing mass spectroscopy and proteinomics.
Adminstratively: • Served on large
number of committees intramurally: search committees for clinical directors, scientific directors; served as the sole scientist on the
New Business System steering committee, and chairing committee for the new CRIS committee-computer for hospital and clinical research • Chairing intramural committee for the implementation plan for Clinical research conduct and patient safety. To be harmonized
with recommendations for the outside committee • As ARVO president, organized that group's first retreat and strategic plan
which is now being implemented. One of the goals of the strategic plan was to protect the present system of study sections and to enhance
ARVO's lobbying capabities. • Has run for many years a successful fellowship program for clinicians interested in Ocular inflammatory
disease. Take two fellows/year and consistently fill the slots through the match.
Presently: • Chief of the Laboratory
of Immunology • Chief of the Office of Protocol Services, CC, NIH. Responsible for the administrative handling of the 1100 protocols
on the NIH campus. Preparing a web-based protocol writing system (ProtoType) which will be used at NIH and linked to an adverse events
reporting system as well as to the new clinical research information system (CRIS) at the NIH. • Senior advisor to the Deputy
Director of Intramural Research, NIH
S. C. Pflugfelder, Houston, TX
Stephen C. Pflugfelder, M.D. is a graduate of Colgate University and SUNY Upstate Medical
University Syracuse. He did his Ophthalmology residency at Baylor College of Medicine, followed by a Cornea fellowship at the Bascom
Palmer Eye Institute of the University of Miami School of Medicine. He was appointed to the faculty of the Bascom Palmer Eye Institute
in 1985 and was promoted to Professor in 1998. He joined the faculty of the Cullen Eye Institute of Baylor College of Medicine as a
Professor and Director of the Ocular Surface Center in July 2000. He was awarded the James and Margaret Elkins Chair in Ophthalmology
at the Baylor College of Medicine in 2001. He has published over 120 research articles, book chapters and monographs on diseases and
surgery of the cornea and the ocular surface. He was included in the 2001-2002 "Best Doctors in America". He served as the Chairman
of the American Academy of Ophthalmology Lifelong Education for Ophthalmologists Committee and is currently a member of the American
Academy of Ophthalmology Preferred Practice Pattern Committee on Corneal and Ocular Surface diseases. He is on the Editorial Boards
of the journals Cornea, American Journal of Ophthalmology, The CLAO Journal and The Ocular Surface. He is the Secretary of
the Tear Film and Ocular Surface Society. His research interests include the role of inflammation in dry eye and corneal bioengineering.
H. R. Taylor, Melbourne, Australia
Professor Hugh R. Taylor AC is Ringland Anderson Professor and Chairman of the Department of Ophthalmology
at the University of Melbourne. He is also the Director of Eye Services at the Royal Victorian Eye & Ear Hospital, Managing Director
of the Centre for Eye Research Australia, the Regional Chairman for the International Agency for the Prevention of Blindness in the Western
Pacific, and Chair LIII, Academia Ophthalmologica Internationalis.
Professor Taylor's principal research interest centres around
public health, and his population-based studies in Australia have defined the agenda for eye research and for the development of eye
care delivery programmes in this country. He is an acknowledged international authority on onchocerciasis and trachoma and serves on
a multitude of international boards and advisory committees that are concerned with the control of blinding conditions. He has received
numerous prestigious awards and honours, including the 2001 AAO International Blindness Prevention Award and the ARVO Mildred Weisenfeld
Award for 2002.
Professor Taylor has published nine books, more than 420 articles, 50 chapters and in excess of 100 reviews and letters,
most of which deal with the prevention or control of blindness in the developing world.
F. Topouzis, Thessaloniki, GreeceAssistant Professor of Ophthalmology at the Aristotle University of Thessaloniki Fotis Topouzis received his MD in Medicine from the Aristotle
University of Thessaloniki, Greece in 1986. Topouzis pursued residency training in Ophthalmology at the "Saint-Antoine" Hospital and
National Center of Ophthalmology "Quinze Vingts" Hospital Paris, France in 1990. In 1992 he received his Ph.D. in Psychophysics at the
Democritus University of Thrace, Alexandroupolis, Greece. He completed his Fellowship in comprehensive ophthalmology and cornea at the
National Center of Ophthalmology "Quinze Vingts" Hospital Paris, France as "Assistant Specialiste des Hopitaux de Paris" in 1993. He
completed his Fellowship in glaucoma at the Jules Stein Eye Institute, Los Angeles, CA, USA in 1998. Topouzis joined the Department of
Ophthalmology at the Aristotle University of Thessaloniki in 1998 until 2000 as University Associate. He has served at the Department
of Ophthalmology, "Papageorgiou" hospital as Consultant-Interim Director of the department in 1999 until 2000. In 2001 he became Lecturer
in Ophthalmology at the Aristotle University of Thessaloniki and he is the Head and Founder of the Laboratory of Research and Clinical
Applications in Ophthalmology. Dr Topouzis has participated one visiting professorship: Jules Stein Eye Institute, Los Angeles, CA.
He also served as an Assistant Professor at the Department of Ophthalmology, Democritus University of Thrace, Alexandroupolis, Greece.
Dr Topouzis has received the distinguished foreign resident Award from the College of Medicine of the Hospitals in Paris, Post -Doctoral
Award from the Aristotle University of Thessaloniki, Greece and Shaffer International Fellowship Award from the Glaucoma Research Foundation,
San Fransisco, CA.
Dr Topouzis is currently on three scientific panels and committees: GlaucoGENE a Special Interest Group of the
European Glaucoma Society, Bioethical Committee of "Papageorgiou" Hospital, Thessaloniki, Greece, GeEpNet, Special Interest Group of
genetic epidemiology of the Aristotle University of Thessaloniki, Greece (http://lipid.med.auth.gr).
Dr Topouzis serves
three medical journal editorial boards and as a reviewer for ten medical journals. Dr Topouzis is especially interested in epidemiology
and clinical and genetic research in ophthalmic diseases with particular focus in glaucoma and age related macular degeneration. He is
Principal Investigator of two large population-based studies (Thessaloniki Eye Study, Eureye Study).
D. T. Tse, Miami, FL
Dr. David T. Tse is Professor of Ophthalmology and a member of the Ophthalmic Plastic, Orbital Surgery and
Oncology Service at the Bascom Palmer Eye Institute in Miami, Florida.
He received his medical degree from the University of Miami
School of Medicine. His ophthalmology residency was completed at the University of Southern California in Los Angeles. Following residency,
he completed ophthalmic plastic surgery fellowship training at the University of Iowa. He then joined the University of Iowa faculty
in 1982 and stayed until 1986 when Dr. Edward Norton, founder of the Bascom Palmer Eye Institute, invited him to start the Ophthalmic
Plastic Service in Miami.
Dr. Tse is the recipient of the El-Maghraby International Award, USC/Doheny Distinguished Alumnus Award,
and the University of Miami Invention Recognition Award. He is recognized in Woodard/White's "The Best Doctors in America." He has had
over 47 visiting professorships and delivered 5 named lectures. Dr. Tse has edited the Color Atlas of Ophthalmic Surgery: Oculoplastic
Surgery and has authored more than 100 book chapters and peer-reviewed scientific articles. He is a member of several major ophthalmologic
professional societies, including the American Ophthalmological Society. He is on the Editorial Board of Ophthalmic Plastic and Reconstructive
Surgery Journal and currently serves as a Director of the American Board of Ophthalmology.
Dr. Tse's clinical interests include
the full spectrum of lacrimal, eyelid and orbital reconstructive surgeries due to disease or injury, as well as aesthetic and rejuvenative
surgeries. His clinical research efforts center on innovative ways to treat extensive skin cancers and lethal orbital malignancies and
in translational research by integrating scientific discovery into clinical reality in terms of diagnostic and therapeutic approaches
to oculoplastic and orbital diseases.
K. R. Wilhelmus, Houston, TX
Kirk R. Wilhelmus, M.D., Ph.D.
Professor Kirk R. Wilhelmus received his
B.A. in mathematics from the University of Indiana (Evansville, IN) in 1971 and his M.D. from Vanderbilt Medical School (Nashville, TN)
in 1975. Wilhelmus pursued residency training in Ophthalmology at the Baylor College of Medicine (Houston, TX), serving as chief resident
in 1979. He completed his clinical fellowship in corneal and external disease at the Moorfields Eye Hospital (London, UK) in 1981.
Wilhelmus joined the Department of Ophthalmology at the Baylor College of Medicine in 1981. Since 1982, he has served as Director of
the Sid W. Richardson Ocular Microbiology Laboratory. In 1986 he became the Medical Director of the Lions Eye Bank of Texas. In 1998
he received his M.P.H. in epidemiology and completed his Ph.D. in epidemiology in 2002 at the University of Texas School of Public Health
(Houston, TX). Dr. Wilhelmus has participated in three visiting professorships: Brisbane Australia, Kathmandu Nepal, and Hyderabad
India.
Dr. Wilhelmus has received the Everett L. Goar Research Award, the Senior Honor Award from the American Academy of Ophthalmology,
the R. Townley Paton award from the Eye Bank Association of America, and the Secretariat Award from the American Academy of Ophthalmology.
Dr. Wilhelmus is currently on four scientific panels and committees: the Medical Advisory Board for the Eye Bank Association of America,
the Advisory Panel on Ophthalmology for the United States Pharmacopeial Convention, the Transportation Safety Committee for the Texas
Ophthalmological Association, and as Chairman of the Corneal and External Disease panel for the Ophthalmic Knowledge Base of the American
Academy of Ophthalmology. He was the President of the Ocular Microbiology and Immunology Group, a Board member for the Eye Bank Association
of America, and President of the South Central Region of the Eye Bank Association of America.
Dr. Wilhelmus is the author or coauthor
of more than 200 publications. Wilhelmus currently serves on the three ophthalmology journal editorial boards and as a reviewer for seven
ophthalmology journals.
T. Y. Wong, Melboune, Australia
Tien Wong, MD, PhD is currently Professor and Deputy Chair of the Department of Ophthalmology, University
of Melbourne. He is also the Director of the Retinal Vascular Imaging Centre at the Center for Eye Research Australia. Dr. Wong completed
medical school from the National University of Singapore, and ophthalmology residency at the Singapore National Eye Centre. He has medical
retinal fellowship training at the University of Sydney. He has also completed two research fellowships, at the Dana Center for Preventive
Ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital (1997) and at the University of Wisconsin, Madison (2001). He holds a MPH
and PhD degrees from the Johns Hopkins University School of Public Health.
Dr. Wong's clinical and research expertise is in the area
of retinal vascular diseases, including diabetic and hypertensive retinopathy, retinal vein occlusion, and age-related macular degeneration.
Dr. Wong has published 180 peer-reviewed articles, and presented more than 50 named and invited lectures. He holds numerous grants and
is the Principal Investigator of research projects in Australia, USA, and Singapore.
Dr. Wong is on the Editorial Board of the American
Journal of Ophthalmology, Investigative Ophthalmology and Visual Sciences, and Ophthalmic Epidemiology. He is an elected
Chair of the Program Committee in the Clinical Epidemiology section of ARVO.
Dr Wong has been recognized internationally with numerous
awards, including the Asia Pacific Academy of Ophthalmology Prevention of Blindness (2003) and Distinguished Service (2005) Award, the
Sandra Doherty Award from the American Heart Association (2004), the Woodward Medal in Science and Technology from the University of
Melbourne (2005), the Alcon Award from the Alcon Research Institute, USA (2006), the Novartis Prize in Diabetes, Young Investigator (2006),
and, most recently, the Australian Health Minister's Award for Excellence in Health and Medical Research (2006).
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company